How many clinical trials are there for Recurrent Malignant Germ Cell Tumor?

PlainTrial tracks 8 US clinical trials for Recurrent Malignant Germ Cell Tumor, of which 1 are currently recruiting.

Which interventions appear most often on Recurrent Malignant Germ Cell Tumor trial records?

Computed Tomography is the most-linked intervention name on Recurrent Malignant Germ Cell Tumor records (3 trial links), followed by Bone Marrow Aspiration and Biopsy. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Recurrent Malignant Germ Cell Tumor?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Recurrent Malignant Germ Cell Tumor: early-phase trial registry

Compiled by PlainTrial · August 8, 2026

1 of 8 indexed Recurrent Malignant Germ Cell Tumor trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

8 US clinical trials · 1 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Recurrent Malignant Germ Cell Tumor: 8 US clinical trials tracked, 1 recruiting.

Recurrent Malignant Germ Cell Tumor is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 7 of these trials.

Enrollment posture brief

Registry condition recurrent-malignant-germ-cell-tumor

Volume-matched condition peers

Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)

Open-enrollment share among volume-matched conditions near Recurrent Malignant Germ Cell Tumor

Recurrent Malignant Germ Cell Tumor lists 1 open slots (13% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Recurrent Malignant Germ Cell Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Recurrent Malignant Germ Cell Tumor is recruiting below its size-band peers.

1 of 8 indexed trials (12.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
One sponsor concentrates Recurrent Malignant Germ Cell Tumor research.

National Cancer Institute (NCI) accounts for 7 of 8 trials (87.5%). 2 distinct sponsors appear on at least one study for this condition label.
Most Recurrent Malignant Germ Cell Tumor trials plan to enrol fewer than 100 people.

Median target enrolment is 13 among the 8 trials that report a genuine target (sentinel values excluded). 8 of those (100%) plan for fewer than 100 participants.
Recurrent Malignant Germ Cell Tumor research is mostly interventional.

8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Open and recent trials

8 total, page 1 of 1

RECRUITING Phase 1 90 participants

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

NCT04901702

ACTIVE NOT RECRUITING Phase 2 20 participants